Related Experiment Video
Updated: Feb 7, 2026

Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Hotspot DAXX, PTCH2 and CYFIP2 mutations in pancreatic neuroendocrine neoplasms
T Vandamme1,2, M Beyens1, G Boons1
1Center of Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.
Abstract:
Mutations in DAXX/ATRX, MEN1 and genes involved in the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway have been implicated in pancreatic neuroendocrine neoplasms (pNENs). However, mainly mutations present in the majority of tumor cells have been identified, while proliferation-driving mutations could be present only in small fractions of the tumor. This study aims to identify high- and low-abundance mutations in pNENs using ultra-deep targeted resequencing. Formalin-fixed paraffin-embedded matched tumor-normal tissue of 38 well-differentiated pNENs was sequenced using a HaloPlex targeted resequencing panel. Novel amplicon-based algorithms were used to identify both single nucleotide variants (SNVs) and insertion-deletions (indels) present in >10% of reads (high abundance) and in <10% of reads (low abundance). Found variants were validated by Sanger sequencing. Sequencing resulted in 416,711,794 reads with an average target base coverage of 2663 ± 1476. Across all samples, 32 high-abundance somatic, 3 germline and 30 low-abundance mutations were withheld after filtering and validation. Overall, 92% of high-abundance and 84% of low-abundance mutations were predicted to be protein damaging. Frequently, mutated genes were MEN1, DAXX, ATRX, TSC2, PI3K/Akt/mTOR and MAPK-ERK pathway-related genes. Additionally, recurrent alterations on the same genomic position, so-called hotspot mutations, were found in DAXX, PTCH2 and CYFIP2. This first ultra-deep sequencing study highlighted genetic intra-tumor heterogeneity in pNEN, by the presence of low-abundance mutations. The importance of the ATRX/DAXX pathway was confirmed by the first-ever pNEN-specific protein-damaging hotspot mutation in DAXX. In this study, both novel genes, including the pro-apoptotic CYFIP2 gene and hedgehog signaling PTCH2, and novel pathways, such as the MAPK-ERK pathway, were implicated in pNEN.
Insights
Ultra-deep sequencing revealed low-abundance mutations in pancreatic neuroendocrine neoplasms (pNENs), highlighting genetic heterogeneity. This study identified novel mutations and pathways, including the MAPK-ERK pathway, implicating genes like DAXX and ATRX in pNEN development.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Pancreatic neuroendocrine neoplasms (pNENs) are often associated with mutations in DAXX/ATRX, MEN1, and the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway.
- Previous studies primarily identified high-abundance mutations, potentially overlooking low-abundance variants that could drive tumor proliferation.
- Understanding the full spectrum of genetic alterations in pNENs is crucial for diagnosis and treatment.
Purpose of the Study:
- To identify both high- and low-abundance mutations in pNENs using ultra-deep targeted resequencing.
- To investigate genetic intra-tumor heterogeneity in pNENs.
- To uncover novel genes and pathways involved in pNEN development.
Main Methods:
- Ultra-deep targeted resequencing of formalin-fixed paraffin-embedded matched tumor-normal tissue from 38 well-differentiated pNENs using a HaloPlex panel.
- Application of novel amplicon-based algorithms to detect single nucleotide variants (SNVs) and insertion-deletions (indels) at high (>10% reads) and low (<10% reads) abundance.
- Validation of identified variants using Sanger sequencing.
Main Results:
- Sequencing generated over 416 million reads with an average coverage of 2663x.
- 32 high-abundance and 30 low-abundance somatic mutations were identified and validated, with 92% and 84% predicted to be protein-damaging, respectively.
- Frequently mutated genes included MEN1, DAXX, ATRX, TSC2, and genes in the PI3K/Akt/mTOR and MAPK-ERK pathways. Novel hotspot mutations were found in DAXX, PTCH2, and CYFIP2.
Conclusions:
- This study demonstrates significant genetic intra-tumor heterogeneity in pNENs, characterized by the presence of low-abundance mutations.
- The importance of the ATRX/DAXX pathway in pNENs is reinforced, with the discovery of the first pNEN-specific protein-damaging hotspot mutation in DAXX.
- Novel genes (CYFIP2, PTCH2) and pathways (MAPK-ERK) are implicated in pNEN pathogenesis, opening new avenues for research and therapeutic strategies.
More Related Videos
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift
Point and Frameshift Mutations
Mutations in Microorganisms

